Author Archive
David Hilzenrath
Oversight
10 doctors on an FDA panel reviewing Abbott heart device had financial ties with the company
Some familiar with the process said the payments should have been disclosed in the interest of transparency.
- David Hilzenrath and Holly K. Hacker, KFF Health News